XML 18 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 16,374 $ 12,681
Adjustments to reconcile net income to net cash provided by operating activities:    
Change in fair value of derivatives 7 6
Depreciation and amortization of deferred leasing costs 11,035 10,440
Amortization of deferred debt costs 332 362
Non cash compensation costs of stock grants and options 293 256
Provision for credit losses 432 246
(Increase) decrease in accounts receivable and accrued income 2,051 (1,144)
Additions to deferred leasing costs (1,468) (1,169)
Decrease in prepaid expenses 1,262 587
Increase in other assets (1,357) (730)
Increase in accounts payable, accrued expenses and other liabilities 3,486 2,064
Decrease in deferred income (1,150) (406)
Net cash provided by operating activities 31,297 23,193
Cash flows from investing activities:    
Acquisitions of real estate investments 0 (893)
Additions to real estate investments (4,150) (2,712)
Additions to development and redevelopment projects (9,658) (7,019)
Net cash used in investing activities (13,808) (10,624)
Cash flows from financing activities:    
Proceeds from notes payable 0 30,000
Repayments on notes payable (6,047) (20,914)
Proceeds from revolving credit facility 6,000 4,000
Repayments on revolving credit facility (11,000) (21,000)
Proceeds from construction loan 9,377 3,377
Additions to deferred debt costs 24 (183)
Proceeds from the issuance of:    
Common stock 3,273 5,315
Partnership units 1,613 1,180
Distributions to:    
Series C preferred stockholders (3,094) (3,094)
Common stockholders (9,145) (8,379)
Noncontrolling interests (3,141) (2,879)
Net cash used in financing activities (12,140) (12,577)
Net increase (decrease) in cash and cash equivalents 5,349 (8)
Cash and cash equivalents, beginning of period 10,003 12,128
Cash and cash equivalents, end of period $ 15,352 $ 12,120